Research

Official NEBA Releases

Integration of an EEG biomarker with a clinician’s ADHD evaluation
NEBA Health Releases Key Study Results
NEBA Health Key Results Summary
ACAAP 2013 - poster: Evaluation of a method that integrates an EEG biomarker with a clinician's assessment of ADHD
FDA.gov - FDA permits marketing of first brain wave test to help assess children and teens for ADHD (external link)
FDA.gov - De Novo Classification Request For Neuropsychiatric EEG-Based Assessment Aid for ADHD (NEBA) System (external link)
Biological Markers in Diagnosis of ADHD: EEG Theta/Beta Ratio in Diagnosis of ADHD. Pediatric Neurology Briefs. (external link)